All news
Showing 32 out of 32 results
Herbert Smith Freehills advises sponsors on Simcere Pharmaceutical’s HK$3.57 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为先声药业35.7亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities …
Herbert Smith Freehills advises sponsors on Peijia Medical’s HK$2.34 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为沛嘉医疗23.4亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors of medical device …
HERBERT SMITH FREEHILLS ADVISES ON LUPIN'S DIVESTMENT OF KYOWA PHARMACEUTICAL
Leading global law firm Herbert Smith Freehills is advising Nanomi B.V., a subsidiary of Lupin Limited, on the sale of its entire stake in its Japanese …
Herbert Smith Freehills advises on second Hong Kong pharma IPO in less than one week
Leading global law firm Herbert Smith Freehills has advised the joint sponsors of the IPO of SinoMab BioScience Limited on the Main Board of the Stock …
Herbert Smith Freehills advises on TOT BIOPHARM's Hong Kong Listing
Leading global law firm Herbert Smith Freehills has advised ICBC International Capital Limited as the sole sponsor of the IPO and listing of TOT BIOPHARM …
Herbert Smith Freehills’ finance team tops Debtwire Loans League Tables as preferred borrowers’ legal adviser
Herbert Smith Freehills has solidified its position as a leading loans legal advisor by topping Debtwire’s 2019 Loans League Tables for Borrowers’ Legal …
Herbert Smith Freehills tops Asia-Pacific M&A league tables
Herbert Smith Freehills’ reputation as the pre-eminent law firm for mergers and acquisitions across Asia Pacific has been reinforced, with the firm …
Herbert Smith Freehills advises Mitsui on strategic acquisition of a 10% interest in Russia's R-Pharm
Showing 32 out of 32 results